Literature DB >> 15534162

Relationship between obesity and B-type natriuretic peptide levels.

James McCord1, Brian J Mundy, Michael P Hudson, Alan S Maisel, Judd E Hollander, William T Abraham, Philip G Steg, Torbjørn Omland, Cathrine W Knudsen, Keisha R Sandberg, Peter A McCullough.   

Abstract

BACKGROUND: The relationships among B-type natriuretic peptide (BNP) levels, body mass index (BMI), and congestive heart failure (CHF) as an emergency diagnosis are unknown.
METHODS: Of 1586 participants in the Breathing Not Properly Multinational Study who had acute dyspnea, 1369 (86.3%) had BNP values and self-reported height and weight. Two independent cardiologists masked to the BNP results adjudicated the final diagnosis.
RESULTS: Congestive heart failure was found in 46% of participants. Individuals with higher BMIs were younger and had more frequent edema on examination but were equally as likely to have CHF vs noncardiac sources of dyspnea. A nearly 3-fold difference was seen in mean +/- SD BNP values at the low and high extremes of the BMI groupings (516.7 +/- 505.9 vs 176.3 +/- 270.5 pg/mL, respectively; P< .001). The correlations between BMI and log BNP among those with and without CHF were r = -0.34 and r = -0.21, respectively (P< .001 for both). Multivariate analysis for the outcome of log BNP among a small subset with CHF (n = 62) found that Framingham score (P = .002), estimated glomerular filtration rate (P = .007), female sex (P = .03), New York Heart Association functional class (P = .09), and third heart sound (P = .08) were independent predictors. However, BMI was not found to be independently related to log BNP (P = .59).
CONCLUSIONS: In patients with and without CHF, BNP levels are inversely related to BMI. When considering demographics, severity of disease, and renal function, BMI is not independently related to BNP levels in a small subgroup when detailed information about CHF severity is known.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15534162     DOI: 10.1001/archinte.164.20.2247

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  27 in total

1.  Association of serum triiodothyronine with B-type natriuretic peptide and severe left ventricular diastolic dysfunction in heart failure with preserved ejection fraction.

Authors:  Senthil Selvaraj; Irwin Klein; Sara Danzi; Nausheen Akhter; Robert O Bonow; Sanjiv J Shah
Journal:  Am J Cardiol       Date:  2012-04-11       Impact factor: 2.778

2.  Relation of visceral adiposity to circulating natriuretic peptides in ambulatory individuals.

Authors:  Susan Cheng; Caroline S Fox; Martin G Larson; Joseph M Massaro; Elizabeth L McCabe; Abigail May Khan; Daniel Levy; Udo Hoffmann; Christopher J O'Donnell; Karen K Miller; Christopher Newton-Cheh; Andrea D Coviello; Shalender Bhasin; Ramachandran S Vasan; Thomas J Wang
Journal:  Am J Cardiol       Date:  2011-08-01       Impact factor: 2.778

Review 3.  The paradox of low BNP levels in obesity.

Authors:  Aldo Clerico; Alberto Giannoni; Simona Vittorini; Michele Emdin
Journal:  Heart Fail Rev       Date:  2012-01       Impact factor: 4.214

Review 4.  Canadian Cardiovascular Society Consensus Conference recommendations on heart failure update 2007: Prevention, management during intercurrent illness or acute decompensation, and use of biomarkers.

Authors:  J Malcom O Arnold; Jonathan G Howlett; Paul Dorian; Anique Ducharme; Nadia Giannetti; Haissam Haddad; George A Heckman; Andrew Ignaszewski; Debra Isaac; Philip Jong; Peter Liu; Elizabeth Mann; Robert S McKelvie; Gordon W Moe; John D Parker; Anna M Svendsen; Ross T Tsuyuki; Kelly O'Halloran; Heather J Ross; Vivek Rao; Errol J Sequeira; Michel White
Journal:  Can J Cardiol       Date:  2007-01       Impact factor: 5.223

Review 5.  Early management of patients with acute heart failure: state of the art and future directions. A consensus document from the society for academic emergency medicine/heart failure society of America acute heart failure working group.

Authors:  Sean Collins; Alan B Storrow; Nancy M Albert; Javed Butler; Justin Ezekowitz; G Michael Felker; Gregory J Fermann; Gregg C Fonarow; Michael M Givertz; Brian Hiestand; Judd E Hollander; David E Lanfear; Phillip D Levy; Peter S Pang; W Frank Peacock; Douglas B Sawyer; John R Teerlink; Daniel J Lenihan
Journal:  J Card Fail       Date:  2014-07-18       Impact factor: 5.712

Review 6.  Biomarkers and cardiovascular risk assessment for primary prevention: an update.

Authors:  Lauren G Gilstrap; Thomas J Wang
Journal:  Clin Chem       Date:  2011-11-28       Impact factor: 8.327

7.  Higher natriuretic peptide levels associate with a favorable adipose tissue distribution profile.

Authors:  Ian J Neeland; Benjamin R Winders; Colby R Ayers; Sandeep R Das; Alice Y Chang; Jarett D Berry; Amit Khera; Darren K McGuire; Gloria L Vega; James A de Lemos; Aslan T Turer
Journal:  J Am Coll Cardiol       Date:  2013-04-16       Impact factor: 24.094

8.  Association of parental obesity with concentrations of select systemic biomarkers in nonobese offspring: the Framingham Heart Study.

Authors:  Wolfgang Lieb; Michael J Pencina; Katherine J Lanier; Geoffrey H Tofler; Daniel Levy; Caroline S Fox; Thomas J Wang; Ralph B D'Agostino; Ramachandran S Vasan
Journal:  Diabetes       Date:  2008-10-17       Impact factor: 9.461

9.  The Importance of Amino-terminal pro-Brain Natriuretic Peptide Testing in Clinical Cardiology.

Authors:  Van Kimmenade
Journal:  Biomark Insights       Date:  2007-02-07

10.  N-terminal pro-B-type natriuretic Peptide in overweight and obese patients with and without diabetes: an analysis based on body mass index and left ventricular geometry.

Authors:  Seung Jei Park; Kyoung Im Cho; Sun Jae Jung; Sung Won Choi; Jae Won Choi; Dong Won Lee; Hyeon Gook Lee; Tae Ik Kim
Journal:  Korean Circ J       Date:  2009-12-30       Impact factor: 3.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.